Moringa oleifera and glycemic control: A review of current evidence and possible mechanisms.
Level 5 - mechanism / opinion, no new human data
Narrative review primarily summarizing preclinical (in vitro and animal) studies without a systematic human meta-analysis.
PubMed 31429148 · doi:10.1002/ptr.6473
What was done
The authors reviewed literature published through February 2019 evaluating the effects of *Moringa oleifera* leaves on glycemic regulation and their physiological mechanisms in diabetes and prediabetes.
What was found
The abstract reports no numerical data, study counts, or effect sizes. It reports that moringa leaves demonstrated blood glucose-lowering effects without adverse events in the reviewed literature. Reported mechanisms include inhibition of α-amylase and α-glucosidase activities, decreased intestinal glucose uptake, reduced hepatic gluconeogenesis, increased glucose uptake in muscle and liver, and enhanced insulin secretion and sensitivity.
Why it matters
This paper consolidates proposed biological pathways through which *Moringa oleifera* may influence glucose metabolism, pointing out the gap between preclinical findings and human clinical trials.
Limits
The abstract provides no quantitative metrics or counts of included studies. The evidence base consists mostly of in vitro and animal models, meaning clinical efficacy, optimal dosage, active ingredients, and long-term safety in humans remain unconfirmed.
Cited by
- supports A review of six small clinical studies demonstrated an effect of moringa leaves or moringa leaf powder on blood glucose control.